Infectious Disease Rapid Diagnostic Testing Market Forecast (2024-2031)
The Infectious Disease Rapid Diagnostic Testing Market is expected to register a CAGR of 9.0% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on product (assay, instruments), and by disease type (hepatitis, HIV, HAIS, HPV, TB, influenza, other diseases). The report provides analysis based ontechnology (immunodiagnostics, clinical microbiology, PCR, INAAT, others). The report further provides analysis based onuser (hospitals, clinics, diagnostic laboratories, others). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Infectious Disease Rapid Diagnostic Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Infectious Disease Rapid Diagnostic Testing Market Segmentation
Product- Assay
- Instruments
- Hepatitis
- HIV
- HAIS
- HPV
- TB
- Influenza
- Other Diseases
- Immunodiagnostics
- Clinical Microbiology
- PCR
- INAAT
- Others
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Strategic Insights
Infectious Disease Rapid Diagnostic Testing Market Growth Drivers- Rising Cases of Infectious Diseases: Governments and health groups are making rapid diagnostics a top priority to improve how they watch for and respond to diseases. As infectious diseases become more common, the need for quick testing solutions will keep growing. This creates profitable chances for companies in the market.
- Growing Awareness and Acceptance: Public health campaigns and educational initiatives have educated people about symptoms and transmission and people are taking a proactive approach to testing. Acceptance of rapid tests especially during outbreaks like COVID-19 has proven their value in managing public health crisis. Healthcare professionals and patients are recognizing the convenience and speed of rapid testing and hence adoption is increasing.
- Regulatory Support: Funding from governments and health organizations are key drivers in the infectious disease rapid diagnostic testing market. Authorities are simplifying the approval process for new diagnostic technologies so that they can reach the market faster. Initiatives like Global Health Security Agenda (GHSA) is focused on improving diagnostic capabilities globally and creating an enabling environment for innovation. This supportive regulatory environment with funding enables companies to develop and commercialize advanced diagnostic solutions and drive the market growth.
- Adoption of Artificial Intelligence (AI): The ability of AI to generate and exploit big data, allows for enhanced diagnostic accuracy, as such methods can analyze information and uncover irregularities that traditional methods may not have discerned. Such predictive analytics through machine learning algorithms may help on forecasting disease incidence and patient results, thus enabling timely interventions by the healthcare providers.
- Advancing Multiplex Testing Platforms: Development of multiplex testing allows detection of multiple pathogens also from a single sample, which is important in the management of co-infections. Clinical strategies based on the rapid diagnosis of multiple infectious agents improve clinical practice, especially in the case of emergency medical help. As the health issues on a global level get complicated, multipurpose diagnostic tests, such as multiplex tests, will be indispensable which will in turn help in the development and use of such services.
- Expansion of Point-of-Care Testing (POCT) :The other significant trend in the infectious rapid diagnostic testing market is the expansion of POCT. It allows performing diagnostic tests on the site or within the immediate vicinity of the patient, thereby offering the patients an opportunity to receive a timely diagnosis and treatment, without delays. Such a transformation is particularly relevant for remote or rural geographical settings where the presence of a laboratory is impractical.
- Strategic Partnerships and Collaborations: Strategic partnerships with providers of healthcare services, research institutes, and technology firms are likely to invite new growth opportunities. Working with strategic players of the healthcare system allows firms to improve their market share, speed up the development cycles of the products in the pipeline, and increase the capacity to reach more customers, which results in an upsurge in sales revenue.
- Focus on Emerging Markets : Developing countries provide an immense potential for the growth share of the market in infectious diseases, rapid diagnosis testing industry. With development of healthcare infrastructure in regions like Asia-Pacific and Latin America, rise in demand for such holistic diagnostic and therapeutic solutions is anticipated. By gaining entry and establishing a strong foothold in such developing markets, the players can aim at attracting the new customer groups which will result in the increase of the revenues over a protracted period of time.
- R&D in Advancing Products:The value of investing particularly in research and development (R&D) is that it opens doors for market players to be creative and avoid any competition. Companies can focus on developing advanced on-site rapid diagnostic tests that integrate technologies like CRISPR, nanotechnology, or biosensor that are easier to manufacture and cheaper to deploy, and more accurate and faster.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Infectious Disease Rapid Diagnostic Testing Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Infectious Disease Rapid Diagnostic Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Asia Pacific region is likely to witness the fastest growth rate during the forecast period.
North America dominated the infectious disease rapid diagnostic testing market in 2023
Advancing multiplex testing platforms is likely to remain the key trend during the forecast period.
The market drivers include the increasing surgical procedures, technological advancements, and rising awareness about infection control.
C R Bard Inc Stryker Cook Degania Silicone Ltd Poly Medicure Limited Global Medikit Limited Romsons Cardinal Health B Braun Melsungen AG
The infectious disease rapid diagnostic testing market is estimated to witness a CAGR of 9.0% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infectious Disease Rapid Diagnostic Testing Market - By Product
1.3.2 Infectious Disease Rapid Diagnostic Testing Market - By Disease Type
1.3.3 Infectious Disease Rapid Diagnostic Testing Market - By Technology
1.3.4 Infectious Disease Rapid Diagnostic Testing Market - By End User
1.3.5 Infectious Disease Rapid Diagnostic Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING - GLOBAL MARKET OVERVIEW
6.2. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ASSAY
7.3.1. Overview
7.3.2. Assay Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
8. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
8.1. OVERVIEW
8.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
8.3. HEPATITIS
8.3.1. Overview
8.3.2. Hepatitis Market Forecast and Analysis
8.4. HIV
8.4.1. Overview
8.4.2. HIV Market Forecast and Analysis
8.5. HAIS
8.5.1. Overview
8.5.2. HAIs Market Forecast and Analysis
8.6. HPV
8.6.1. Overview
8.6.2. HPV Market Forecast and Analysis
8.7. TB
8.7.1. Overview
8.7.2. TB Market Forecast and Analysis
8.8. INFLUENZA
8.8.1. Overview
8.8.2. Influenza Market Forecast and Analysis
8.9. OTHER DISEASES
8.9.1. Overview
8.9.2. Other Diseases Market Forecast and Analysis
9. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. IMMUNODIAGNOSTICS
9.3.1. Overview
9.3.2. Immunodiagnostics Market Forecast and Analysis
9.4. CLINICAL MICROBIOLOGY
9.4.1. Overview
9.4.2. Clinical Microbiology Market Forecast and Analysis
9.5. PCR
9.5.1. Overview
9.5.2. PCR Market Forecast and Analysis
9.6. INAAT
9.6.1. Overview
9.6.2. INAAT Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. DIAGNOSTIC LABORATORIES
10.5.1. Overview
10.5.2. Diagnostic Laboratories Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Infectious Disease Rapid Diagnostic Testing Market Overview
11.1.2 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.1.3 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.1.4 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.1.5 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.1.6 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.1.7 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Infectious Disease Rapid Diagnostic Testing Market
11.1.7.1.1 United States Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.1.2 United States Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.1.3 United States Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.1.4 United States Infectious Disease Rapid Diagnostic Testing Market by End User
11.1.7.2 Canada Infectious Disease Rapid Diagnostic Testing Market
11.1.7.2.1 Canada Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.2.2 Canada Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.2.3 Canada Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.2.4 Canada Infectious Disease Rapid Diagnostic Testing Market by End User
11.1.7.3 Mexico Infectious Disease Rapid Diagnostic Testing Market
11.1.7.3.1 Mexico Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.3.2 Mexico Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.3.3 Mexico Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.3.4 Mexico Infectious Disease Rapid Diagnostic Testing Market by End User
11.2. EUROPE
11.2.1 Europe Infectious Disease Rapid Diagnostic Testing Market Overview
11.2.2 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.2.3 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.2.4 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.2.5 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.2.6 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Infectious Disease Rapid Diagnostic Testing Market
11.2.7.1.1 Germany Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.1.2 Germany Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.1.3 Germany Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.1.4 Germany Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.2 France Infectious Disease Rapid Diagnostic Testing Market
11.2.7.2.1 France Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.2.2 France Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.2.3 France Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.2.4 France Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.3 Italy Infectious Disease Rapid Diagnostic Testing Market
11.2.7.3.1 Italy Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.3.2 Italy Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.3.3 Italy Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.3.4 Italy Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.4 Spain Infectious Disease Rapid Diagnostic Testing Market
11.2.7.4.1 Spain Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.4.2 Spain Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.4.3 Spain Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.4.4 Spain Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.5 United Kingdom Infectious Disease Rapid Diagnostic Testing Market
11.2.7.5.1 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.5.2 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.5.3 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.5.4 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.6 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market
11.2.7.6.1 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.6.2 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.6.3 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.6.4 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Overview
11.3.2 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.3.5 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.3.6 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Infectious Disease Rapid Diagnostic Testing Market
11.3.7.1.1 Australia Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.1.2 Australia Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.1.3 Australia Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.1.4 Australia Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.2 China Infectious Disease Rapid Diagnostic Testing Market
11.3.7.2.1 China Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.2.2 China Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.2.3 China Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.2.4 China Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.3 India Infectious Disease Rapid Diagnostic Testing Market
11.3.7.3.1 India Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.3.2 India Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.3.3 India Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.3.4 India Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.4 Japan Infectious Disease Rapid Diagnostic Testing Market
11.3.7.4.1 Japan Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.4.2 Japan Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.4.3 Japan Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.4.4 Japan Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.5 South Korea Infectious Disease Rapid Diagnostic Testing Market
11.3.7.5.1 South Korea Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.5.2 South Korea Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.5.3 South Korea Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.5.4 South Korea Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.6 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market
11.3.7.6.1 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.6.2 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.6.3 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.6.4 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Overview
11.4.2 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.4.5 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.4.6 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Infectious Disease Rapid Diagnostic Testing Market
11.4.7.1.1 South Africa Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.1.2 South Africa Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.1.3 South Africa Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.1.4 South Africa Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market
11.4.7.2.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.2.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.2.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.2.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.3 U.A.E Infectious Disease Rapid Diagnostic Testing Market
11.4.7.3.1 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.3.2 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.3.3 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.3.4 U.A.E Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.4 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market
11.4.7.4.1 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.4.2 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.4.3 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.4.4 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Infectious Disease Rapid Diagnostic Testing Market Overview
11.5.2 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.5.3 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.5.4 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.5.5 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.5.6 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Infectious Disease Rapid Diagnostic Testing Market
11.5.7.1.1 Brazil Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.1.2 Brazil Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.1.3 Brazil Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.1.4 Brazil Infectious Disease Rapid Diagnostic Testing Market by End User
11.5.7.2 Argentina Infectious Disease Rapid Diagnostic Testing Market
11.5.7.2.1 Argentina Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.2.2 Argentina Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.2.3 Argentina Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.2.4 Argentina Infectious Disease Rapid Diagnostic Testing Market by End User
11.5.7.3 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market
11.5.7.3.1 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.3.2 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.3.3 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.3.4 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BECTON DICKINSON AND COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOMéRIEUX SA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DANAHER CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIO-RAD LABORATORIES
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SIEMENS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. DIASORIN
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LUMINEX
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERIDIAN BIOSCIENCE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROCHE DIAGNOSTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Becton Dickinson and Company
3. Biomérieux SA
4. Danaher Corporation
5. Bio-Rad Laboratories
6. Siemens AG
7. Diasorin
8. Luminex
9. Meridian Bioscience
10. Roche Diagnostics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For